RISK OF INVASIVE FUNGAL INFECTIONS WITH TUMOR NECROSIS FACTOR-ALPHA INHIBITORS AND CORTICOSTEROIDS AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Gregory, Martin H.
Spec, Andrej
Stwalley, Dustin
Gremida, Anas K.
Mejia-Chew, Carlos
Nickel, Katelin B.
Ciorba, Matthew A.
Rood, Richard P.
Olsen, Margaret A.
Deepak, Parakkal
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
18
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [1] Corticosteroids Increase the Risk of Invasive Fungal Infections More Than Tumor Necrosis Factor-Alpha Inhibitors in Patients With Inflammatory Bowel Disease
    Gregory, Martin H.
    Spec, Andrej
    Stwalley, Dustin
    Gremida, Anas
    Mejia-Chew, Carlos
    Nickel, Katelin B.
    Ciorba, Matthew A.
    Rood, Richard P.
    Olsen, Margaret A.
    Deepak, Parakkal
    CROHNS & COLITIS 360, 2023, 5 (02)
  • [2] Incidence and Risk Factors for Invasive Fungal Infections in Patients Initiating Tumor Necrosis Factor-Alpha Inhibitors for Inflammatory Bowel Disease and Rheumatoid Arthritis
    Hennessee, Ian
    Benedict, Kaitlin
    Bahr, Nathan C.
    Lipner, Shari R.
    Gold, Jeremy A. W.
    CLINICAL INFECTIOUS DISEASES, 2024, 80 (02) : 364 - 366
  • [3] Dermatoses in patients with inflammatory bowel disease under tumor necrosis factor-alpha inhibitors treatment
    Magalhaes, Carolina Mundim Couto
    Bartholo, Marina Ribeiro
    Correa, Bernardo Henrique Mendes
    Ferrari, Maria de Lourdes Abreu
    Ferrari, Teresa Cristina Abreu
    MEDICINA CLINICA, 2025, 164 (04): : 173 - 177
  • [4] Risk of Myeloid Neoplasms in Inflammatory Bowel Disease Patients Is Linked to Exposure to Thiopurines and Not With Tumor Necrosis Factor-alpha Inhibitors
    Deepak, Parakkal
    Stobaugh, Derrick J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (10) : 1857 - 1858
  • [5] Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Jansson-Knodell, Claire L.
    Harris, Courtney E.
    Loftus, Edward V., Jr.
    Walker, Randall C.
    Enzler, Mark J.
    Virk, Abinash
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (01) : 190 - 198
  • [6] Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Claire L. Jansson-Knodell
    Courtney E. Harris
    Edward V. Loftus
    Randall C. Walker
    Mark J. Enzler
    Abinash Virk
    Digestive Diseases and Sciences, 2021, 66 : 190 - 198
  • [7] Risk of Pancreatitis With Tumor Necrosis Factor-Alpha Inhibitors Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System
    Stobaugh, Derrick J.
    Samo, Salih
    Deepak, Parakkal
    Ehrenpreis, Eli D.
    GASTROENTEROLOGY, 2014, 146 (05) : S583 - S584
  • [8] Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease
    Lee, Wan-Ju
    Lee, Todd A.
    Calip, Gregory S.
    Suda, Katie J.
    Briars, Leslie
    Schumock, Glen T.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (04) : 883 - 891
  • [9] Tumor Necrosis Factor-alpha Gene Polymorphisms in Korean Children with Inflammatory Bowel Disease
    Cho, Min Sung
    Song, Seung Min
    Oh, Seak Hee
    Lee, Yeoun Joo
    Jang, Ju Young
    Kim, Kyung Mo
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2011, 14 (03) : 269 - 278
  • [10] Association of tumor necrosis factor-alpha and -beta gene polymorphisms in inflammatory bowel disease
    Al-Meghaiseeb, Ebtissam Saleh
    Al-Robayan, Abdulrahman A.
    Al-Otaibi, Mulfi Mubarak
    Arfin, Misbahul
    Al-Asmari, Abdulrahman K.
    JOURNAL OF INFLAMMATION RESEARCH, 2016, 9 : 133 - 140
12345